CANNABIELSOIC ACID B (CBEA-B)

Cannabinoids are a group of chemical compounds that may be found in either marijuana or the cannabis plant. The medicinal and non-psychoactive properties of these chemical structures are well-known.

​

These substances are either naturally produced or manufactured synthetically. Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN), Cannabigerol (CBG), Cannabavarin (THCV), delta-8-THC, Cannabichromene (CBC), Cannabitriol (CBT), Cannabicyclol (CBL), and cannabielsoin are some of the naturally occurring cannabinoids.

​

Cannabielsoin is the family to which Cannabielsoic acid B (CBEA-B) belongs, even though it is a metabolic active agent derived from CBE.

​

The natural products of CBE-type compounds is widely questioned because of their infrequent identification and/or isolation from natural sources. They can be formed through the process of photo-oxidation or pyrolysis.

CBE-like chemicals can be produced when CBD and CBD acids go through any of these processes. Despite these reservations, CBE and CBE acid (both the C3 and C5 homologues) have been reported as natural products of Cannabis sativa plant material or hashish on multiple occasions.

​

The working nature of CBEA-B

 

There have been no sufficient proven results of how each of these ingredients, including Cannabielsoic acid B (CBEA-B), reacts in the body and what effect they bring, even though cannabis and medical marijuana have been used for years and there are many psychoactive ingredients present in the plants that relate to the receptors in the human body.

Much about Cannabielsoic acid B's therapeutic properties has yet to be revealed (CBEA-B). However, cannabielsoic acid B (CBEA-B) may be able to help with:

• Cancer

• Multiple sclerosis

• Epilepsy

• Chronic pain

• Addiction to drugs and alcoholism

• PTSD stands for post-traumatic stress disorder (PTSD)

• Depression